The India Cements (INDIACEM) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
1 Sep, 2025Executive summary
Unaudited standalone and consolidated results for the quarter and half-year ended 30 September 2024 were reviewed and approved on 8 November 2024.
The company is primarily engaged in cement manufacturing, with subsidiaries in sugar, power, financial services, trading, mining, and transportation.
Financial highlights
Standalone revenue from operations for Q2 FY25 was ₹1,016.65 crore, down from ₹1,222.13 crore in Q2 FY24; half-year revenue was ₹1,988.18 crore versus ₹2,615.17 crore year-over-year.
Standalone net loss for Q2 FY25 was ₹239.98 crore, compared to a net loss of ₹81.39 crore in Q2 FY24; half-year net loss was ₹182.52 crore versus ₹156.66 crore year-over-year.
Consolidated revenue from operations for Q2 FY25 was ₹1,031.80 crore, down from ₹1,264.39 crore in Q2 FY24; half-year consolidated revenue was ₹2,058.56 crore versus ₹2,701.13 crore year-over-year.
Consolidated net loss for Q2 FY25 was ₹339.13 crore, compared to a net loss of ₹80.07 crore in Q2 FY24; half-year consolidated net loss was ₹280.66 crore versus ₹167.47 crore year-over-year.
Outlook and guidance
The company expects substantial cash inflows from the return of loans and advances from subsidiaries and associates, which are anticipated to alleviate operational stress.
Management remains confident of addressing cash flow concerns, contingent on regulatory approvals for the ongoing acquisition and open offer.
Latest events from The India Cements
- Sales and EBITDA improved as expansion, brand transition, and restructuring progressed.INDIACEM
Q2 25/263 Feb 2026 - Sales up 25% YoY, revenue higher, but net losses persist amid expansion and legal risks.INDIACEM
Q3 25/262 Feb 2026 - Sales volume up to 11.6% YoY, EBITDA/ton improved, losses narrowed, double-digit growth targeted.INDIACEM
Q1 25/266 Jan 2026 - Profitability returned in Q1 FY25 on an exceptional gain, with major stake sale to UltraTech Cement.INDIACEM
Q1 24/251 Sep 2025 - Q3 FY25 saw lower revenue, major losses, UltraTech's takeover, and large asset revaluation gains.INDIACEM
Q3 24/251 Sep 2025 - FY25 saw deeper losses, lower revenue, and major legal disputes, with auditors' unmodified opinions.INDIACEM
Q4 24/251 Sep 2025